|
DNAJA3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.049040E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.293970E-01 |
| Normal-vs-Stage2 |
1.333550E-01 |
| Normal-vs-Stage3 |
6.023900E-03 |
| Normal-vs-Stage4 |
9.405500E-02 |
| Stage1-vs-Stage2 |
1.609630E-02 |
| Stage1-vs-Stage3 |
1.088640E-01 |
| Stage1-vs-Stage4 |
5.805600E-01 |
| Stage2-vs-Stage3 |
1.677550E-03 |
| Stage2-vs-Stage4 |
1.184370E-02 |
| Stage3-vs-Stage4 |
5.116200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.375600E-02 |
| Normal-vs-AfricanAmerican |
3.002200E-01 |
| Normal-vs-Asian |
2.765000E-01 |
| Caucasian-vs-AfricanAmerican |
7.541600E-01 |
| Caucasian-vs-Asian |
6.353400E-01 |
| AfricanAmerican-vs-Asian |
9.682400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.055600E-02 |
| Normal-vs-Female |
2.338600E-01 |
| Male-vs-Female |
1.582810E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.981500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.256410E-01 |
| Normal-vs-Age(61-80Yrs) |
7.384600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.846200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.659200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.313000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.212000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.831200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.932200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.037200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.973220E-01 |
| Classical-VS-Follicular |
3.915700E-03 |
| Classical-VS-Other |
2.846800E-01 |
| Classical-VS-Normal |
3.918200E-02 |
| Tall-VS-Follicular |
8.979000E-04 |
| Tall-VS-Other |
6.616800E-01 |
| Tall-VS-Normal |
6.980900E-03 |
| Follicular-VS-Other |
1.162790E-01 |
| Follicular-VS-Normal |
1.825950E-01 |
| Other-VS-Normal |
3.842000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.214400E-01 |
| Normal-vs-N1 |
1.078010E-03 |
| N0-vs-N1 |
4.063500E-03 |
|
|
